Site Map
About Heart Failure
- Mechanism of Disease
- Disease Progression
About Heart Failure
HFrEF
HFpEF with LVEF ≤60%*
- Clinical & Biomarker Data
HFpEF with LVEF ≤60%*
Safety & Dosing
About ENTRESTO®
- Dual Mechanism of Action
About ENTRESTO®
Skip to main content
Important Safety Information
BOXED WARNING: FETAL TOXICITY
- When pregnancy is detected, discontinue ENTRESTO as soon as possible
- Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus
ENTRESTO is contraindicated in patients with hypersensitivity to any component...
Indication
ENTRESTO is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal.
LVEF is a variable measure, so use clinical judgment in deciding whom to treat.
Click or scroll to see IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING AND INDICATION